作者：
Ledermann,J. [1]
;
Harter,P. [2]
;
Gourley,C. [3]
;
Friedlander,M. [4]
;
Vergote,I. [5]
;
Rustin,G. [6]
;
Scott,C.L. [7]
;
Meier,W. [8]
;
Shapira-Frommer,R. [9]
;
Safra,T. [10]
;
Matei,D. [11]
;
Fielding,A. [12]
;
Spencer,S. [13]
;
Dougherty,B. [14]
;
Orr,M. ;
Hodgson,D. ;
Barrett,J.C. ;
Matulonis,U.
作者单位：
Prince of Wales Clinical School, University of New South Wales, Randwick, NSW, Australia
[1]
University of Edinburgh Cancer Research UK Centre, MRC Institute of Genetics and Molecular Medicine
[2]
Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
[3]
AstraZeneca, Macclesfield, Cheshire, United Kingdom
[4]
Indiana University School of Medicine, Indianapolis, IN, United States
[5]
UCL Cancer Institute, University College London, London, United Kingdom
[6]
AstraZeneca, Waltham, MA, United States
[7]
University of Leuven, Leuven, Belgium
[8]
Mount Vernon Hospital, Northwood, Middlesex, United Kingdom
[9]
Dana-Farber Cancer Institute, Boston, MA, United States
[10]
Evangelisches Krankenhaus, Düsseldorf, Germany
[11]
Chaim Sheba Medical Center, Tel Hashomer, Israel
[12]
Kliniken Essen Mitte, Essen, Germany
[13]
Royal Melbourne Hospital, Parkville, NSW, Australia
[14]
发布时间
2015-02-03
换一批
